help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on July 24, 2008, doi:10.1164/rccm.200712-1822OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200712-1822OCv1
178/6/605    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Hong, S.-B.
Right arrow Articles by Garcia, J. G. N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hong, S.-B.
Right arrow Articles by Garcia, J. G. N.
American Journal of Respiratory and Critical Care Medicine Vol 178. pp. 605-617, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200712-1822OC


Original Article

Essential Role of Pre–B-Cell Colony Enhancing Factor in Ventilator-induced Lung Injury

Sang-Bum Hong1,2, Yong Huang3, Liliana Moreno-Vinasco1, Saad Sammani1, Jaideep Moitra1, Joseph W. Barnard4, Shwu-Fan Ma1, Tamara Mirzapoiazova1, Carrie Evenoski1, Ryan R. Reeves1, Eddie T. Chiang1, Gabriel D. Lang1, Aliya N. Husain5, Steven M. Dudek1, Jeffrey R. Jacobson1, Shui Q. Ye6, Yves A. Lussier3 and Joe G. N. Garcia1

1 Section of Pulmonary and Critical Care Medicine, Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois; 2 University of Ulsan College of Medicine, Seoul, Korea; 3 Section of Genetic Medicine, Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois; 4 Division of Pulmonary and Critical Care, Johns Hopkins University, Baltimore, Maryland; 5 Department of Pathology, Pritzker School of Medicine, University of Chicago, Chicago, Illinois; and 6 University of Missouri, Columbia, Missouri

Correspondence and requests for reprints should be addressed to Joe G. N. Garcia, M.D., Lowell T. Coggeshall Professor of Medicine, Department of Medicine, University of Chicago Pritzker School of Medicine, 5841 S. Maryland Avenue, W604, Chicago, IL 60637. E-mail: jgarcia{at}medicine.bsd.uchicago.edu

Rationale: We previously demonstrated pre–B-cell colony enhancing factor (PBEF) as a biomarker in sepsis and sepsis-induced acute lung injury (ALI) with genetic variants conferring ALI susceptibility.

Objectives: To explore mechanistic participation of PBEF in ALI and ventilator-induced lung injury (VILI).

Methods: Two models of VILI were utilized to explore the role of PBEF using either recombinant PBEF or PBEF+/– mice.

Measurements and Main Results: Initial in vitro studies demonstrated recombinant human PBEF (rhPBEF) as a direct rat neutrophil chemotactic factor with in vivo studies demonstrating marked increases in bronchoalveolar lavage (BAL) leukocytes (PMNs) after intratracheal injection in C57BL/6J mice. These changes were accompanied by increased BAL levels of PMN chemoattractants (KC and MIP-2) and modest increases in lung vascular and alveolar permeability. We next explored the potential synergism between rhPBEF challenge (intratracheal) and a model of limited VILI (4 h, 30 ml/kg tidal volume) and observed dramatic increases in BAL PMNs, BAL protein, and cytokine levels (IL-6, TNF-{alpha}, KC) compared with either challenge alone. Gene expression profiling identified induction of ALI- and VILI-associated gene modules (nuclear factor-{kappa}B, leukocyte extravasation, apoptosis, Toll receptor pathways). Heterozygous PBEF+/– mice were significantly protected (reduced BAL protein, BAL IL-6 levels, peak inspiratory pressures) when exposed to a model of severe VILI (4 h, 40 ml/kg tidal volume) and exhibited significantly reduced expression of VILI-associated gene expression modules. Finally, strategies to reduce PBEF availability (neutralizing antibody) resulted in significant protection from VILI.

Conclusions: These studies implicate PBEF as a key inflammatory mediator intimately involved in both the development and severity of ventilator-induced ALI.

Key Words: visfatin • acute lung injury • chemotaxis • apoptosis • mechanical ventilation


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Pre–B-cell colony enhancing factor (PBEF), whose gene variants are associated with ventilator-induced lung injury (VILI) susceptibility, has been identified as a potential VILI candidate gene and biomarker and has been localized to animal and human lung epithelium in acute lung injury. The mechanism of this association remains unknown.

What This Study Adds to the Field
This study implicates PBEF as a key inflammatory mediator in the development and severity of VILI in murine models of VILI. PBEF may be a molecular target for amelioration of VILI in critically ill patients.

 



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
N. J. Meyer and J. D. Christie
Extracellular Superoxide Dismutase Haplotypes and Acute Lung Injury: Reading into the Genome to Understand Mortality?
Am. J. Respir. Crit. Care Med., January 15, 2009; 179(2): 89 - 91.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society
  ATS Sleep Tracings Quiz